Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-170 in moderately active Crohn's disease
NL-OMON36043Phase 2Active, not recruiting
- Sponsor
- Toray Industries
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TRK-170 in Crohn's disease and inflammatory bowel disease (IBD), sponsored by Toray Industries. Started Oct 2011; status: active, not recruiting.
02
Drugs
TRK-170
03
Conditions
Crohn's diseaseinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON36043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36043.